NIH-funded research R01 grant

Finding new ways to relieve pain without dangerous side effects

Official title: Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia

Funded at University of Texas Hlth Science Center · NIH-10914772 · Data updated 2026-11-12

This study is exploring new ways to relieve pain without the harmful side effects of opioids, aiming to find safer treatments that work directly on the nerves that sense pain, so people can feel better without the risk of addiction.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center
NIH-funded
Lab location1 site (San Antonio, United States)
Project startSeptember 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$508,286
NIH project number5R01DA057787-02
Project IDNIH-10914772 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 who experience nociceptive pain and are seeking alternative pain management options.

Less likely to help

Patients who do not experience pain or have conditions unrelated to nociceptive pain may not benefit from this research.

What this research studies

This research focuses on developing new pain relief methods that avoid the dangerous side effects associated with traditional opioid medications. The team is investigating a specific receptor combination in pain-sensing neurons that, when activated, can provide effective pain relief. By identifying small molecules that can selectively activate these receptors, the research aims to create safer analgesic drugs that target pain at its source. This approach could lead to innovative treatments that help manage pain without the risk of addiction or respiratory issues.

Why it matters

Potential benefit: If successful, this research could lead to the development of safer pain relief medications that minimize the risk of addiction and other severe side effects.

How similar studies have gone: Previous research has shown promise in targeting receptor combinations for pain relief, indicating that this approach could be a viable alternative to traditional analgesics.

Where this research is happening

  • University of Texas Hlth Science Center
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Clarke, William P — University of Texas Hlth Science Center
  • Study coordinator: Clarke, William P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.